000 01843 a2200505 4500
005 20250517052533.0
264 0 _c20160921
008 201609s 0 0 fre d
022 _a0151-9638
024 7 _a10.1016/j.annder.2015.06.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMunoz, J
245 0 0 _a[Type I interferonopathies].
_h[electronic resource]
260 _bAnnales de dermatologie et de venereologie
_cNov 2015
300 _a653-63 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAortic Diseases
_ximmunology
650 0 4 _aAutoimmune Diseases
_ximmunology
650 0 4 _aAutoimmune Diseases of the Nervous System
_xgenetics
650 0 4 _aChilblains
_ximmunology
650 0 4 _aDental Enamel Hypoplasia
_ximmunology
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_ximmunology
650 0 4 _aJanus Kinases
_xantagonists & inhibitors
650 0 4 _aLupus Erythematosus, Cutaneous
_ximmunology
650 0 4 _aMetacarpus
_xabnormalities
650 0 4 _aMuscular Diseases
_ximmunology
650 0 4 _aNervous System Malformations
_xgenetics
650 0 4 _aOdontodysplasia
_ximmunology
650 0 4 _aOsteochondrodysplasias
_ximmunology
650 0 4 _aOsteoporosis
_ximmunology
650 0 4 _aProteasome Endopeptidase Complex
_ximmunology
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
650 0 4 _aSkin
_xpathology
650 0 4 _aSyndrome
650 0 4 _aTreatment Outcome
650 0 4 _aVascular Calcification
_ximmunology
700 1 _aMarque, M
700 1 _aDandurand, M
700 1 _aMeunier, L
700 1 _aCrow, Y-J
700 1 _aBessis, D
773 0 _tAnnales de dermatologie et de venereologie
_gvol. 142
_gno. 11
_gp. 653-63
856 4 0 _uhttps://doi.org/10.1016/j.annder.2015.06.018
_zAvailable from publisher's website
999 _c25255454
_d25255454